<DOC>
	<DOC>NCT01941394</DOC>
	<brief_summary>Infusion of Mesenchymal Stem Cell (MSC) at day of recovery after bone marrow transplant (BMT) for patients with AL, AA and MM for acute Graft-versus-host Disease (GVHD) prophylaxis and treatment.</brief_summary>
	<brief_title>Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation</brief_title>
	<detailed_description>Infusion of mesenchymal stem cells at day of recovery after BMT for patients with AL, AA and MM for acute GVHD prophylaxis and treatment. Infusion at dose 1 cells mln/kg at day of white blood cells recovery.</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Graft vs Host Disease</mesh_term>
	<criteria>allogenic BMT from related or unrelated donor Severe infection Relapse admission to ICU refusal of research patients with graft failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>GVHD</keyword>
	<keyword>Relapse</keyword>
	<keyword>Overall Survival</keyword>
</DOC>